ImmunityBio Shares Fall 19% on Revenue Miss, Going-Concern Warning
ImmunityBio shares fell 19% to US$6.97 after revenue missed consensus and a US$184.6 million loss widened. ANKTIVA sales rose 53%, but a going-concern warning dominated.
Topic
Revenue
Topic
Revenue
Anthropic Revenue Climbs 46% to $16.8 Billion Ahead of IPO
Anthropic's revenue jumped 46% to $16.8 billion ahead of its IPO, per Analytics India Magazine — but the report leaves margins, t…
Anthropic Revenue Jumps 45% to $16.8bn Ahead of Expected Listing
Anthropic's revenue jumped 45% to $16.8bn in the quarter to end-September, per the BBC, as the Claude developer lays groundwork f…
OpenAI's Revenue Is $20 Billion Below Earlier Projections
OpenAI told investors annualized revenue is nearing $50 billion — about $20 billion below the $70 billion figure reported a week…
Three Fashion Brands Hit $100 Million With No Outside Money
Three fashion brands have each passed $100 million in revenue without outside investment, per a Glossy briefing on bootstrapped a…
Gritsee Hires Franchise Veteran Paige Robinson Dosch as SVP of Revenue
Gritsee has appointed franchise industry veteran Paige Robinson Dosch as Senior Vice President of Revenue, signaling a push into…
BYD's Overseas Revenue Now Exceeds China as Margins Improve
BYD's overseas revenue hit RMB 181.3 billion in H1 2026, 53% of total sales, at a 22% margin, offsetting a price-war hit at home…
DeepSeek Revenue Nears $500 Million as IPO Talk Builds
DeepSeek's revenue is closing in on $500 million as the Chinese AI startup weighs an IPO, putting it among the revenue leaders of…